VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
October 7, 2022
Re: | Facible BioDiagnostics, Inc. |
Post-Qualification Amendment on Form 1-A POS | |
File No. 024-11878 |
To Whom It May Concern:
On behalf of Facible BioDiagnostics, Inc. (the “Company”), I hereby request qualification of the above-referenced post-qualification amendment at 5:00 pm, Eastern Time, on Friday, October 7, 2022, or as soon thereafter as is practicable.
Sincerely,
/s/ Brian Geoghegan
Brian Geoghegan, Esq.
Regulation D Resources